Quinn, Terence JTaylor-Rowan, MartinCoyte, AishaClark, AllanMusgrave, StanleyMetcalf, AnthonyDay, Diana JBachmann, MaxWarburton, Elizabeth APotter, JohnMyint, Phyo K2017-06-132017-06-132017-06-13Quinn, T J, Taylor-Rowan, M, Coyte, A, Clark, A, Musgrave, S, Metcalf, A, Day, D J, Bachmann, M, Warburton, E A, Potter, J & Myint, P K 2017, 'Pre-Stroke Modified Rankin Scale : Evaluation of Validity, Prognostic Accuracy, and Association with Treatment', Frontiers in Neurology, vol. 8, 275. https://doi.org/10.3389/fneur.2017.00275ORCID: /0000-0003-3852-6158/work/163198973http://hdl.handle.net/2164/8803The Anglia Stroke Clinical Network Evaluation Study (ASCNES) is funded by the National Institute of Health Research (NIHR) for Patient Benefit Program (PB-PG-1208-18240). This paper presents independent research commissioned by the NIHR under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-1208-18240). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. TQ is supported by a Stroke Association/Chief Scientist Office Scotland Senior Clinical Lectureship. MT-R is jointly supported by Chest Heart and Scotland award and University of Glasgow bequest, his work is part of a Stroke Association/Chief Scientist Office program grant.171717engmodified rankindisabilitystrokeoutcomecomplicationsprognosisR MedicineRPre-Stroke Modified Rankin Scale : Evaluation of Validity, Prognostic Accuracy, and Association with TreatmentJournal article10.3389/fneur.2017.002758